Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma with Prior Disease Progression (vol 39, pg 215, 2021)

Cheung I. Y.

首页> 外文期刊>Journal of Clinical Oncology >Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma with Prior Disease Progression (vol 39, pg 215, 2021)

【24h】

Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma with Prior Disease Progression (vol 39, pg 215, 2021)

机译：抗GD2抗体反应在高危神经母细胞瘤患者中抗GD2抗体反应对高危神经母细胞瘤的疾病进展（Vol 39，PG 215,2021）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Clinical Oncology 》 |2021年第4期| 共1页
作者
Cheung I. Y.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学 ;
关键词

相似文献

外文文献

1. Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression [J] . Cheung Irene Y., Cheung Nai-Kong V., Modak Shakeel, Journal of Clinical Oncology . 2021 ,第3期

机译：抗GD2抗体反应在高危神经母细胞瘤患者中抗GD2抗体反应对患者的抗GD2抗体反应的影响
2. Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival [J] . Cheung Irene Y., Kushner Brian H., Modak Shakeel, Oncoimmunology. . 2017 ,第11期

机译：I相试验抗GD2单克隆抗体HU3F8加上GM-CSF：体重，免疫原性和抗GD2对药代动力学和存活的影响
3. Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial [J] . Ladenstein Ruth, Poetschger Ulrike, Valteau-Couanet Dominique, The lancet oncology . 2018 ,第12期

机译：白细胞介素2具有抗GD2抗体CH14.18 / CHO（DINUTUXIMABβ）高危神经母细胞瘤（HR-NBL1 / SIOPEN）：多期，随机，第3阶段试验
4. Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight immunogenicity and anti-GD2 response on pharmacokinetics and survival [O] . Irene Y. Cheung, Brian H. Kushner, Shakeel Modak, 2017

机译：抗GD2单克隆抗体hu3F8加GM-CSF的I期试验：体重免疫原性和抗GD2反应对药代动力学和存活率的影响
5. Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival [O] . Irene Y. Cheung, Brian H. Kushner, Shakeel Modak, 2017

机译：抗GD2单克隆抗体HU3F8加上GM-CSF的I相试验：体重，免疫原性和抗GD2对药代动力学和生存的影响

Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma with Prior Disease Progression (vol 39, pg 215, 2021)

著录项

相似文献

相关主题

期刊订阅